SILVIA SQUILLACE

PhD Graduate

PhD program:: XXXI



Thesis title: NOVEL PROMISING PHARMACOLOGICAL TARGETS AND DRUGS FOR THE TREATMENT OF NEUROPATHIC PAIN: FOCUSING ON PROKINETICIN SYSTEM AND SELECTIVE A3 ADENOSINE RECEPTOR (A3AR) AGONISTS IN AN ANIMAL MODEL.


Research products

11573/1604635 - 2021 - The balance of concentration between Prokineticin 2β and Prokineticin 2 modulates the food intake by STAT3 signaling
Maftei, Daniela; Lattanzi, Roberta; Vincenzi, Martina; Squillace, Silvia; Fullone, Maria Rosaria; Miele, Rossella - 01a Articolo in rivista
paper: BBA ADVANCES () pp. 100028- - issn: 2667-1603 - wos: (0) - scopus: 2-s2.0-85119583395 (10)

11573/1309377 - 2019 - The prokineticin receptor antagonist PC1 rescues memory impairment induced by β amyloid administration through the modulation of prokineticin system
Maftei, D.; Ratano, P.; Fusco, I.; Marconi, V.; Squillace, Silvia; Negri, L.; Severini, Cristina; Balboni, G.; Steardo, L.; Bronzuoli, M. R.; Scuderi, C.; Campolongo, P.; Lattanzi, R. - 01a Articolo in rivista
paper: NEUROPHARMACOLOGY (Elsevier Science Limited:Oxford Fulfillment Center, PO Box 800, Kidlington Oxford OX5 1DX United Kingdom:011 44 1865 843000, 011 44 1865 843699, EMAIL: asianfo@elsevier.com, tcb@elsevier.co.UK, INTERNET: http://www.elsevier.com, http://www.elsevier.com/locate/shpsa/, Fax: 011 44 1865 843010) pp. - - issn: 0028-3908 - wos: WOS:000488998500029 (17) - scopus: 2-s2.0-85070721933 (18)

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma